SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001185185-23-000688
Filing Date
2023-07-07
Accepted
2023-07-06 17:52:34
Documents
16
Period of Report
2023-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K igcpharma20230706_8k.htm   iXBRL 8-K 33599
2 EXHIBIT 10.1 ex_541546.htm EX-10.1 154019
3 EXHIBIT 99.1 ex_541547.htm EX-99.1 8654
8 igc_logo1.jpg GRAPHIC 10449
  Complete submission text file 0001185185-23-000688.txt   378660

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA igc-20230630.xsd EX-101.SCH 3182
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igc-20230630_def.xml EX-101.DEF 11004
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE igc-20230630_lab.xml EX-101.LAB 21038
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igc-20230630_pre.xml EX-101.PRE 11405
10 EXTRACTED XBRL INSTANCE DOCUMENT igcpharma20230706_8k_htm.xml XML 2599
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

IRS No.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-32830 | Film No.: 231074659
SIC: 2834 Pharmaceutical Preparations